| Original language | English |
|---|---|
| Title of host publication | Advances in Surgical and Medical Specialties |
| Publisher | Taylor and Francis |
| Pages | 305-316 |
| Number of pages | 12 |
| ISBN (Electronic) | 9781000602746 |
| ISBN (Print) | 9789814877459 |
| Publication status | Published - 23 Jun 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Alirocumab
- Atherogenic dyslipidaemia
- Atherosclerosis
- Atorvastatin
- Bococizumab
- Canakinumab
- Cardiovascular disease
- Combination therapy
- Evolocumab
- Ezetimibe
- Ezetimibe-atorvastatin therapy
- Familial hypercholesterolaemia (FH)
- Fenofibrate
- Hyper-cholesterolaemia
- Inclisiran
- Ischaemic stroke
- Low-density lipoprotein cholesterol (LDL-C)
- Low-dose methotrexate
- Myocardial infarction
- PCSK9 inhibition therapy
- Polypill
- Proprotein convertase subtilisin/kexin type 9 (PCSK9)
- Ribonucleic acid (RNA)
- Rosuvastatin
- Simvastatin
- Small interfering ribonucleic acid
- Statin intolerance
- Statin potency
- Statin-ezetimibe combination therapy
- Statin-fibrate combinations
- Statins
- Unstable angina
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver